These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2998408)

  • 1. Adenosine triphosphate pyrophosphohydrolase and neutral inorganic pyrophosphatase in pathologic joint fluids. Elevated pyrophosphohydrolase in calcium pyrophosphate dihydrate crystal deposition disease.
    Rachow JW; Ryan LM
    Arthritis Rheum; 1985 Nov; 28(11):1283-8. PubMed ID: 2998408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synovial fluid inorganic pyrophosphate concentration and nucleotide pyrophosphohydrolase activity in basic calcium phosphate deposition arthropathy and Milwaukee shoulder syndrome.
    Rachow JW; Ryan LM; McCarty DJ; Halverson PC
    Arthritis Rheum; 1988 Mar; 31(3):408-13. PubMed ID: 2833903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial characterization of synovial fluid nucleotide pyrophosphohydrolase.
    Rachow JW; Ryan LM
    Arthritis Rheum; 1985 Dec; 28(12):1377-83. PubMed ID: 2935159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synovial fluid ATP: a potential substrate for the production of inorganic pyrophosphate.
    Ryan LM; Rachow JW; McCarty DJ
    J Rheumatol; 1991 May; 18(5):716-20. PubMed ID: 1650841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inorganic pyrophosphate generation from adenosine triphosphate by cell-free human synovial fluid.
    Park W; Masuda I; Cardenal-Escarcena A; Palmer DL; McCarty DJ
    J Rheumatol; 1996 Apr; 23(4):665-71. PubMed ID: 8730124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated inorganic pyrophosphate concentrations in synovial fluids in osteoarthritis and pseudogout.
    Silcox DC; McCarty DJ
    J Lab Clin Med; 1974 Apr; 83(4):518-31. PubMed ID: 4361744
    [No Abstract]   [Full Text] [Related]  

  • 7. Synovial fluid 5'-nucleotidase activity. Relationship to other purine catabolic enzymes and to arthropathies associated with calcium crystal deposition.
    Wortmann RL; Veum JA; Rachow JW
    Arthritis Rheum; 1991 Aug; 34(8):1014-20. PubMed ID: 1650220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inorganic pyrophosphate, nucleoside triphosphate pyrophosphatase, and cartilage fragments in normal human synovial fluid.
    Hamilton E; Pattrick M; Doherty M
    Br J Rheumatol; 1991 Aug; 30(4):260-4. PubMed ID: 1650620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inorganic pyrophosphatase activity of the synovial fluid. Kinetic and clinical study.
    Jacobelli S; Kettlun AM; Sapag-Hagar M
    Arthritis Rheum; 1978 May; 21(4):447-52. PubMed ID: 26358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synovial fluid pyrophosphate and nucleoside triphosphate pyrophosphatase: comparison between normal and diseased and between inflamed and non-inflamed joints.
    Pattrick M; Hamilton E; Hornby J; Doherty M
    Ann Rheum Dis; 1991 Apr; 50(4):214-8. PubMed ID: 1851409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium pyrophosphate crystal deposition disease and other crystal deposition diseases.
    Fam AG
    Curr Opin Rheumatol; 1992 Aug; 4(4):574-82. PubMed ID: 1503884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleotide pyrophosphohydrolase in human synovial fluid.
    Masuda I; Cardenal A; Ono W; Hamada J; Haas AL; McCarty DJ
    J Rheumatol; 1997 Aug; 24(8):1588-94. PubMed ID: 9263156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence Differentiation of ATP-related Multiple Enzymatic Activities in Synovial Fluid as a Marker of Calcium Pyrophosphate Deposition Disease using Kyoto Green.
    Yongwattana N; Mekjinda N; Tawonsawatruk T; Hamachi I; Ojida A; Wongkongkatep J
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32131555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial chondrocalcinosis due to calcium pyrophosphate dihydrate crystal deposition in English families.
    Doherty M; Hamilton E; Henderson J; Misra H; Dixey J
    Br J Rheumatol; 1991 Feb; 30(1):10-5. PubMed ID: 1846765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of chondrocyte production of extracellular inorganic pyrophosphate.
    Costello JC; Ryan LM
    Curr Opin Rheumatol; 2004 May; 16(3):268-72. PubMed ID: 15103256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The solubility of calcium pyrophosphate dihydrate crystals].
    Sakamoto H
    Nihon Seikeigeka Gakkai Zasshi; 1995 Jul; 69(7):484-92. PubMed ID: 7561350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrophosphohydrolase activity and inorganic pyrophosphate content of cultured human skin fibroblasts. Elevated levels in some patients with calcium pyrophosphate dihydrate deposition disease.
    Ryan LM; Wortmann RL; Karas B; Lynch MP; McCarty DJ
    J Clin Invest; 1986 May; 77(5):1689-93. PubMed ID: 3009553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP pyrophosphohydrolase in human chondrocalcinotic and osteoarthritic cartilage. I. Some biochemical characteristics.
    Muniz O; Pelletier JP; Martel-Pelletier J; Morales S; Howell DS
    Arthritis Rheum; 1984 Feb; 27(2):186-92. PubMed ID: 6141795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inorganic pyrophosphate pool size and turnover rate in arthritic joints.
    Camerlain M; McCarty DJ; Silcox DC; Jung A
    J Clin Invest; 1975 Jun; 55(6):1373-81. PubMed ID: 166095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinico-radiologic aspects of calcium pyrophosphate dihydrate deposition disease].
    Orzincolo C; Castaldi G; Bariani L; Franceschini F; Lodi G; Bariani MC
    Minerva Med; 1987 Mar; 78(5):281-6. PubMed ID: 3029632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.